CTLA4 and neoplasm: One class of ICi, anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) antibodies, prevent CTLA-4 on T-cells from interacting with inhibitory signals on antigen-presenting cells, thereby increasing anti-tumor T-cell response.